Screening tests for migraine applied to the population of the Bauru campus of the University of São Paulo: a prevalence study
Views: 13Keywords:
Migraine disorders, Surveys and questionnaires, PrevalenceAbstract
Introduction: Migraine is a prevalent neurological disorder marked by recurrent and severe headaches that significantly impacts individuals' quality of life. Objective: This study aims to apply migraine screening tools to the population of the Bauru campus of the University of São Paulo (USP) to estimate the prevalence of migraine and assess the impact of pain on daily life.
Methods: A cross-sectional study involved 216 participants, comprising students, faculty, and staff, who completed online questionnaires, including the “ID Migraine,” “International Headache Society Migraine Diagnosis,” and “Migraine Screen Questionnaire.” The impact of migraine on daily activities was assessed using the “Headache Impact Test. The data were analyzed using the Shapiro-Wilk test, Student's t-test, Mann-Whitney test, and Pearson's correlation, adopting a 5% significance level.
Results: Out of 216 respondents, 69 (31.94%) were diagnosed with migraine using the ID Migraine tool. The International Headache Society questionnaire identified 86 participants (39.81%) as having migraine, while the Migraine Screen Questionnaire indicated 94 participants (43.52%). A combined analysis identified 20.83% of participants (n=45) as having migraine across all questionnaires. A total of 113 participants (52.31%) tested positive for migraine in at least one questionnaire. Results also revealed a strong correlation between positive migraine diagnosis and significant limitations in daily activities, as assessed by the Headache Impact Test (p<0.001).
Conclusion: Using multiple migraine screening questionnaires enhances sensitivity and specificity in identifying individuals with migraine. The findings reveal a substantial population at the USP campus likely affected by migraines, emphasizing the need for further research and intervention strategies.
Downloads
References
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan 25;38(1):1–211. Doi: 10.1177/0333102417738202
Rasmussen B. Epidemiology of Headache. Cephalalgia. 1995 Feb 1;15(1):44–67. Doi: 10.1046/j.1468-2982.1995.1501045.x
Bigal ME, Bordini CA, Speciali JG. Etiology and Distribution of Headaches in Two Brazilian Primary Care Units. Headache: The Journal of Head and Face Pain. 2000 Mar 27;40(3):241–7. Doi: 10.1046/j.1526-4610.2000.00035.x
Agosti R. Migraine Burden of Disease: From the Patient’s Experience to a Socio‐Economic View. Headache: The Journal of Head and Face Pain. 2018 May 26;58(S1):17–32. Doi: 10.1111/head.13301
Puledda F, Silva EM, Suwanlaong K, Goadsby PJ. Migraine: from pathophysiology to treatment. J Neurol. 2023 Jul 8;270(7):3654–66. Doi: 10.1007/s00415-023-11706-1
Queiroz LP, Silva Junior AA. The Prevalence and Impact of Headache in B razil. Headache: The Journal of Head and Face Pain. 2015 Feb 6;55(S1):32–8. Doi: 10.1111/head.12511
Bordini CA, Roesler C, Carvalho D de S, Macedo DDP, Piovesan É, Melhado EM, et al. Recommendations for the treatment of migraine attacks - a Brazilian consensus. Arq Neuropsiquiatr. 2016 Mar;74(3):262–71. Doi: 10.1590/0004-282X2015021
Friedman BW, Lipton RB. Headache Emergencies: Diagnosis and Management. Neurol Clin. 2012 Feb;30(1):43–59. Doi: 10.1016/j.ncl.2011.09.008
May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016 Aug 8;12(8):455–64. Doi: 10.1038/nrneurol.2016.93
Queiroz MV de, Medeiros Jr WLG, Eboni ACB, Nogueira EAG, Gonçalves MVM, Sousa NAC, et al. ID-Migraine is a sensitive tool for screening migraine among patients with multiple sclerosis. Headache Medicine. 2019 Mar 31;10(1):2–4. Doi: 10.48208/HeadacheMed.2019.2
Peng KP, Wang SJ. Migraine diagnosis: Screening items, instruments, and scales. Acta Anaesthesiologica Taiwanica. 2012 Jun;50(2):69–73. Doi: 10.1016/j.aat.2012.05.002
Woldeamanuel YW, Cowan RP. Computerized migraine diagnostic tools: a systematic review. Ther Adv Chronic Dis. 2022 Jan 24;13. Doi: 10.1177/20406223211065235
Šukalo A, Merdžanović E, Alic A, Vrabac-Mujčinagić M, Alibašić E, Janković SM. Screening general practice patients for migraine without aura: construction and validation of the Balkan Migraine Screening Questionnaire (BMSQ). Med Glas. 2019 May 10;16(2):311–6. Doi: 10.17392/1021-19
Ertaş M, Baykan B, Tuncel D, Gökçe M, Gökçay F, Şirin H, et al. A Comparative ID MigraineTM Screener Study in Ophthalmology, ENT and Neurology Out-Patient Clinics. Cephalalgia. 2009 Jan 1;29(1):68–75. Doi: 10.1111/j.1468-2982.2008.01702.x
Láinez MJ, Castillo J, Domínguez M, Palacios G, Díaz S, Rejas J. New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care. BMC Neurol. 2010 Dec 8;10(1):39. Doi: 10.1186/1471-2377-10-39
Láinez MJA, Domínguez M, Rejas J, Palacios G, Arriaza E, Garcia‐Garcia M, et al. Development and Validation of the Migraine Screen Questionnaire (MS‐Q). Headache: The Journal of Head and Face Pain. 2005 Nov;45(10):1328–38. Doi: 10.1111/j.1526-4610.2005.00265.x
Pradela J, Bevilaqua‐Grossi D, Chaves TC, Dach F, Carvalho GF. Measurement properties of the Headache Impact Test (HIT‐6TM Brazil) in primary and secondary headaches. Headache: The Journal of Head and Face Pain. 2021 Mar 11;61(3):527–35. Doi: 10.1111/head.14049
Oztora S, Korkmaz O, Dagdeviren N, Celik Y, Caylan A, Top MS, et al. Migraine headaches among university students using id migraine test as a screening tool. BMC Neurol. 2011 Dec 19;11(1):103. Doi: 10.1186/1471-2377-11-103
Valentinis L, Valent F, Mucchiut M, Barbone F, Bergonzi P, Zanchin G. Migraine in Adolescents: Validation of a Screening Questionnaire. Headache: The Journal of Head and Face Pain. 2009 Feb 3;49(2):202–11. Doi: 10.1111/j.1526-4610.2008.01261.x
Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017 Jan;372:307–15. Doi: 10.1016/j.jns.2016.11.071
Benseñor IJM, Lotufo PA, Pereira AC, Tannuri ACA, Issa FKK, Akashi D, et al. Validação de questionário para diagnóstico de cefaléia em ambulatório de hospital universitário. Arq Neuropsiquiatr. 1997 Sep;55(3A):364–9. Doi: 10.1590/S0004-282X1997000300003
Szikszay TM, Hoenick S, von Korn K, Meise R, Schwarz A, Starke W, et al. Which Examination Tests Detect Differences in Cervical Musculoskeletal Impairments in People With Migraine? A Systematic Review and Meta-Analysis. Phys Ther. 2019 May 1;99(5):549–69. Doi: 10.1093/ptj/pzz007
Gervil M, Ulrich V, Olesen J, Russell M. Screening for Migraine in the General Population: Validation of A Simple Questionnaire. Cephalalgia. 1998 Aug 1;18(6):342–8. Doi: 10.1046/j.1468-2982.1998.1806342.x
Speck RM, Collins EM, Lombard L, Ayer DW. A Qualitative Study to Assess the Content Validity of the 24‐Hour Migraine Quality of Life Questionnaire in Patients with Migraine. Headache: The Journal of Head and Face Pain. 2020 Oct 3;60(9):1982–94. Doi: 10.1111/head.13915
Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996 Jul;47(1):52–9. Doi: 10.1212/WNL.47.1.52
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 Jan 30;68(5):343–9. Doi: 10.1212/01.wnl.0000252808.97649.21
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II. Headache: The Journal of Head and Face Pain. 2001 Jul 12;41(7):646–57. Doi:10.1046/j.1526-4610.2001.041007646.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Aline Donata Tanoue, Heitor Marques Honório, Paulo Cesar Rodrigues Conti, Adriano Yacubian Fernandes (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
